Grants for State governments - Food and Nutrition

The Food Safety Education Fund grants program, administered by the Michigan Department of Agriculture & Rural Development (MDARD), is designed to enhance food safety throughout Michigan. Funded by assessments on licensed food establishments, the program aligns with a mission to protect public health by providing critical food safety training and education. This initiative directly supports the broader goal of ensuring a safe food supply for all Michigan residents. The foundation's strategic priority is to prevent foodborne illness through proactive education and the empowerment of various stakeholders within the food system. The program primarily targets two key beneficiary groups: Michigan consumers and food service establishment employees, as well as agents of the director who enforce food regulations (e.g., local health department sanitarians and MDARD food safety inspectors). The impact goal is to improve food safety knowledge and practices among these groups, ultimately reducing the incidence of foodborne illnesses. Eligibility is restricted to Michigan governmental and non-profit organizations and entities, ensuring that the grants support organizations deeply embedded in community health and public service. Producers, marketers, processors, and growers are explicitly excluded to maintain the program's focus on education and training. For the 2024-2025 grant cycle, up to $365,600 is available, with a specific allocation of $242,500 for consumer food safety education and $114,100 for food service establishment employees and regulatory agents. This demonstrates a clear prioritization of widespread public education while also fortifying the knowledge base of those directly involved in food handling and enforcement. The grant duration is typically one year, though multi-year proposals are considered on an individual basis, contingent on future funding availability. Proposals should specifically avoid requesting funding for routine or required training, such as HACCP or ServSafe certification, emphasizing a focus on innovative and supplementary educational initiatives. Proposals are evaluated based on several key criteria, including goals and objectives to improve food safety, assessment of statewide need and audience, measurable outcomes, potential for partnering with other organizations, inclusion of matching funds, and opportunities to build upon previously funded projects. These selection criteria reflect the program's theory of change, which posits that strategic partnerships, evidence-based interventions, and quantifiable results are essential for achieving sustainable improvements in food safety. The expected outcomes include a more informed public, better-trained food service professionals, and more effective enforcement of food safety regulations, all contributing to a safer food environment across Michigan.

The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the full Funding Opportunity Announcement (FOA), that applications for change of recipient organization may be submitted to this FOA. This assumes such a change is programmatically permitted for the particular grant. Applications for change of recipient organization are considered prior approval requests (as described in Section 8.1.2.7 of the NIH Grants Policy Statement) and will be routed for consideration directly to the Grants Management Specialist named in the current award. Although requests for change of recipient organization may be submitted through this FOA, there is no guarantee that an award will be transferred to the new organization. All applicants are encouraged to discuss potential requests with the awarding IC before submission.

Modified release (MR) oral drug products are considered to have a high risk for alcohol dose dumping (ADD) because they contain large quantities of drug(s), designed to release over a prolonged period of time. Accidental exposure of these products to alcohol can result in the relatively rapid release of large quantities of drug with severe side effects, including death. To mitigate this risk, the FDA recommends conducting an in vitro alcohol dose dumping assessment in 0%, 5%, 20%, and 40% alcoholic dissolution media for all prospective generic versions of MR oral drug products. To date, ADD assessments have not been harmonized globally. For instance, the U.S. FDA recommends testing up to 40% alcoholic media while the European Medicines Agency recommends testing up to 20% alcoholic media. This type of difference can present a challenge for formulators designing products for multiple markets, as historical data has shown release from MR oral products do not always follow a linear response (either increasing or decreasing) to increasing alcohol concentrations. In addition, interpretation of an ADD assessment may be limited by the inability of the test to predict in vivo behavior. The purpose of this research is to develop tools that 1) facilitate the development of MR generic drug products that have a low potential for ADD, 2) support regulatory decision making during the assessment of such products, and 3) provide evidence that enables FDA to develop more specific recommendations for efficiently demonstrating a low or comparative potential of alcohol dose dumping for MR oral drug products containing high risk drugs.

This funding opportunity supports researchers in discovering and validating new targets for developing safe and effective pain treatments with minimal side effects and low addiction risk.

This grant provides funding to nonprofit organizations and government entities in El Paso and Teller Counties, Colorado, to promote healthy environments through initiatives that enhance physical activity, improve access to nutritious food, and support affordable housing solutions.

This funding opportunity provides financial support for organizations involved in child nutrition programs in Idaho to upgrade their technology systems and improve operational efficiency.

This Funding Opportunity Announcement (FOA) seeks innovative grant applications in nonmalignant hematology research that will steer the field in new directions. Applications to this FOA should propose proof of principle research that is tightly focused into one specific aim, which can be accomplished within a 1-3 year project period, and is directed at validating novel concepts and approaches that promise to open new pathways for discovery.The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Aging (NIA) have joined together to build research activities in nonmalignant hematology. This Funding Opportunity Announcement (FOA) is intended to promote innovative research projects in nonmalignant hematology that explore high impact and new directions of inquiry. While each Institute shares interests in nonmalignant hematology research, they also bring different perspectives, thereby expanding the scope of the SHINE II program beyond a single Institute's research mission. This "New Directions in Hematology Research (SHINE-II)" program invites investigator-initiated grant applications for basic or early translational, proof of principle research projects that are tightly focused and directed at validating novel concepts and approaches that promise to advance new pathways for discovery. This program may include clinical research involving human subjects that is directed at understanding disease pathogenesis and prognosis. Research applications submitted under this FOA should be more limited in scope (single aim with sub-aims, as appropriate) and duration (1-3 years) than typical R01 grant applications. The SHINE-II FOA seeks specifically to promote and support new directions of research in their early stages. Applications submitted to this FOA should include preliminary data that support the conceptual basis of the research proposed and the technical approaches to be used. Moreover, while research applications submitted under this FOA are expected to be more limited in scope and shorter in duration than typical R01 applications, achievement of the research objective(s) proposed should validate novel pathways of discovery and provide the basis for future high impact research endeavors. Principal areas of interest for this collaborative FOA include: (1) hematopoietic stem cell biology, (2) lineage fate determinants, (3) aging-related immune dysfunction and lymphocyte biology, (4) myeloid cell biology, and myelopoiesis, (5) platelet biology and dysfunction, (6) erythroid cell biology and erythropoiesis, (7) the molecular biology of heme and hemoglobin, (8) acquired and congenital disorders of red blood cell production and survival leading to chronic anemia or bone marrow failure, (9) and the uptake, utilization, storage, and transport of iron in health and disease. Inquiries to Scientific/Research staff prior to submission of an application to this FOA are strongly encouraged to discuss programmatic relevance and potential time tables for funding (see below, Section VII. Agency Contacts). The limited scope and shorter duration of the SHINE II R01 are not optimal for Early Stage Investigators (ESIs) and New Investigators (NIs), who should contact Scientific/Research staff prior to submission of an application to this FOA.

This Notice of Funding Opportunity (NOFO) seeks to support multidisciplinary research teams with complementary expertise in HIV and pathobiology, pathophysiology, and/or metabolism in organs, tissues, and/or biological systems of specific interest to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). These teams will comprehensively interrogate fundamental biological mechanisms underlying HIV-associated comorbidities, co-infections, and complications relevant to the mission of the NIDDK and advance progress toward preventing or alleviating them.

This funding opportunity provides financial support to municipalities and non-profit organizations in Connecticut for environmental assessment and cleanup of brownfield sites, particularly in underserved communities, to promote the creation of parks and recreational spaces.

The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.

Intermountain Health is offering Social Determinants of Health Grants to programs and services that align with their priorities of improving nutrition security and stable, quality housing through wraparound and support services. This grant program is aligned with Intermountain's mission to address critical social determinants of health, recognizing that these factors profoundly impact community well-being. The grants aim to support initiatives that create healthier communities by tackling the root causes of health disparities. The target beneficiaries for these grants are low-income, vulnerable populations, served by social service agencies and healthcare agencies. The impact goals are to improve nutrition security and secure stable and quality housing. Projects are expected to demonstrate a collaborative approach between health and social service agencies, or provide strong health outcomes if an agency applies independently. The grants aim to foster partnerships that lead to comprehensive and sustainable improvements in the lives of these populations. The program's priorities and focuses are explicitly on improving nutrition security and enhancing stable and quality housing through integrated support services. Grant applicants must demonstrate how their program or service directly addresses at least one of these two Intermountain social determinants of health priorities. The theory of change suggests that by directly investing in programs addressing these fundamental needs, Intermountain Health can create a measurable positive impact on community health outcomes. Expected outcomes include improved access to nutritious food and increased access to and retention of stable and quality housing for vulnerable populations. Measurable results will be based on the impact these programs have on the identified social determinants of health, with an emphasis on clearly defined goals and outcomes. For example, successful programs might demonstrate a reduction in food insecurity rates or an increase in the number of individuals securing and maintaining stable housing within the target communities.

The California Natural Resources Agency (CNRA) has launched the Youth Community Access Program, a competitive grant initiative designed to expand outdoor access and foster a healthier California. This program is rooted in supporting youth access to natural or cultural resources, with a specific focus on low-income and disadvantaged communities. While the provided information does not explicitly detail the "foundation's mission alignment" or "strategic priorities and theory of change" in terms of a separate foundation, the CNRA's overarching mission to protect and restore California's natural resources and promote equitable access aligns directly with the program's goals. The program's aim to address and repair the multi-generational community impacts of the War on Drugs further underscores a commitment to social justice and community well-being. The primary beneficiaries of this program are youth, defined as individuals between birth and 26 years old, residing in communities disproportionately affected by past federal and state drug policies, as well as other underserved communities. The impact goals are multifaceted: to promote youth health, safety, well-being, and comfort by facilitating direct access to natural or cultural resources. This includes supporting community education and recreational amenities for youth substance use prevention and early intervention, ultimately empowering youth to make healthy choices and fostering a healthier, more engaged generation. The program prioritizes projects that actively involve youth in all stages, from planning and decision-making to facilitation and evaluation. Additionally, projects that engage youth in outreach and awareness campaigns, and those that empower youth to make healthy choices, are given priority consideration. These focuses emphasize a youth-centric, participatory approach, aiming for sustainable community-led change rather than top-down interventions. The minimum award for an individual project is $25,000, and the maximum is $300,000, indicating a range of project scales supported. While specific measurable results are not explicitly outlined, the expected outcomes can be inferred from the program's requirements and priorities. These include increased youth participation in outdoor and cultural activities, enhanced community capacity for youth development, reduced instances of substance use through prevention and early intervention efforts, and improved overall health and well-being among young people in targeted communities. The emphasis on youth involvement in planning and evaluation suggests an ongoing feedback loop to assess program effectiveness and impact.

The Greenhouse Accelerator Program Juntos Crecemos Edition is a five-month, mentor-guided initiative designed to accelerate emerging Hispanic food and beverage innovations. This program, an extension of the initial Greenhouse Accelerator launched in 2018, is a collaborative effort with PepsiCo Juntos Crecemos, which is part of PepsiCo’s Pep+ transformation agenda. The overarching mission is to provide both short-term and long-term support to Hispanic small businesses, aligning with PepsiCo's broader strategic priorities of driving growth for Hispanic founders within the food and beverage industry in the U.S. and fostering a positive impact through its PepsiCo Positive Strategy. The primary target beneficiaries of this program are up to eight high-potential, emerging Hispanic-owned food and beverage consumer packaged goods small businesses operating in the United States, with net-revenues between $100,000 to $2,000,000 USD in their last financial year. The impact goals are centered on fostering the growth and scalability of these businesses. By providing grants, expert guidance, networking opportunities, and mentorship, the program aims to accelerate pathways for these businesses to launch, scale, and grow their breakthrough innovations, ultimately contributing to the economic empowerment of Hispanic founders. The program prioritizes businesses that demonstrate a clear go-to-market strategy, are post-prototype and ready for review with a multinational corporation, exhibit uniqueness in the market, and possess balanced gender and ethnic diversity. A strong emphasis is also placed on a clear and active social responsibility mission that aligns with PepsiCo’s Juntos Crecemos Strategy and the broader PepsiCo Positive Strategy. The selection committee will also look for scalable business models, indicating the program's focus on long-term sustainability and impact. Expected outcomes include a guaranteed $20,000 USD grant for each finalist, with the winner receiving an additional $100,000 USD, providing crucial financial support. Beyond monetary grants, participants are expected to benefit from expert guidance through learning modules across all aspects of business development, hands-on mentorship for refining business models and strategies, and enhanced impact. The program also offers invaluable access and exposure to the extensive PepsiCo network, industry experts, VCs, and investors, as well as the unlocking of potential collaboration opportunities with PepsiCo. These measurable results collectively aim to strengthen and expand Hispanic-owned businesses in the food and beverage sector.

This initiative provides funding to U.S.-based community organizations and agencies to develop and implement effective solutions that reduce menthol cigarette use among high-risk populations, including youth, LGBTQ+ communities, and racial and ethnic minorities.

This grant provides financial support to U.S.-based for-profit businesses with at least one Latino/x founder, celebrating their contributions and fostering economic growth within the Latino/x community.

This grant provides financial support to farmers and ranchers in the Southern U.S. for small-scale research projects that promote sustainable agricultural practices and address production and marketing challenges.

FDA announces the availability of fiscal year (FY) 2024 funds to support one or more projects to 1) collect antimicrobial use data from diverse animal sectors, including domestic livestock, poultry, companion animals (dogs, cats, and horses), and minor species (e.g., fish, sheep, goats) and 2) contribute to the development of data collection frameworks, including providing data and expertise as resources and a public-private partnership frameworks are established. This grant will support the continued advancement of FDA;apos;s initiatives to support antimicrobial stewardship in veterinary settings. It will also support the National Action Plan objectives to engage the animal health community and relevant stakeholders to advance strategies intended to improve understanding of antimicrobial use and foster antimicrobial stewardship in animal agriculture.

This program provides funding to local organizations in EPA Region 3 for projects that address environmental and health challenges in historically underserved communities.

This funding opportunity supports researchers in planning high-risk, multi-center clinical studies focused on kidney, digestive, diabetes, and metabolic disorders, helping them develop essential protocols and administrative frameworks before conducting the actual trials.

This funding opportunity supports community-based organizations in the Mid-Atlantic region to implement sustainable forestry initiatives that promote environmental justice, improve public health, and create green job opportunities in disadvantaged areas.